Management of Advanced Chronic Kidney Disease During the COVID-19 Pandemic: Suggestions From the Canadian Society of Nephrology COVID-19 Rapid Response Team
暂无分享,去创建一个
[1] Qingbo Xu,et al. Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19 , 2020, Circulation research.
[2] A. Pickles,et al. Treatment with ACE-inhibitors is associated with less severe disease with SARS-Covid-19 infection in a multi-site UK acute Hospital Trust , 2020, medRxiv.
[3] Bolin Wang,et al. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis , 2020, Aging.
[4] F. Messerli,et al. Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect? , 2020, Journal of the American Heart Association.
[5] Marc A Pfeffer,et al. Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19 , 2020, The New England journal of medicine.
[6] G. Lippi,et al. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection , 2020, International Urology and Nephrology.
[7] Ritesh Gupta,et al. Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc) , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.
[8] Centaine L Snoswell,et al. Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19) , 2020, Journal of telemedicine and telecare.
[9] V. Jha,et al. The Novel Coronavirus 2019 epidemic and kidneys , 2020, Kidney International.
[10] Wei Wang,et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis , 2020, European Respiratory Journal.
[11] W. Hoy,et al. Chronic Kidney Disease, Queensland (CKD.QLD) Registry: Management of CKD With Telenephrology , 2018, Kidney international reports.
[12] pTools. COVID-19 Updates , 2018 .
[13] G. Nadkarni,et al. Telenephrology: Providing Healthcare to Remotely Located Patients with Chronic Kidney Disease , 2018, American Journal of Nephrology.
[14] D. Tuot,et al. Role of telehealth in renal replacement therapy education , 2018, Seminars in dialysis.
[15] D. Choudhury,et al. Targeting Access to Kidney Care Via Telehealth: The VA Experience. , 2017, Advances in chronic kidney disease.
[16] I. Schulman,et al. Tele-Nephrology: A Feasible Way to Improve Access to Care for Patients with Kidney Disease Who Reside in Underserved Areas. , 2016, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.
[17] B. Clothier,et al. Telehealth by an Interprofessional Team in Patients With CKD: A Randomized Controlled Trial. , 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[18] Seewon Ryu. Telemedicine: Opportunities and Developments in Member States: Report on the Second Global Survey on eHealth 2009 (Global Observatory for eHealth Series, Volume 2) , 2012, Healthcare Informatics Research.
[19] Mark Chappell,et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury , 2005, Nature Medicine.